On June 12, 2024, Dr. Han Myint, M.D. notified NextCure, Inc. of his plan to retire from his position as Chief Medical Officer of the Company, effective July 1, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.59 USD | -3.05% |
|
-1.85% | +39.47% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+39.47% | 44.48M | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- NXTC Stock
- News NextCure, Inc.
- NextCure, Inc. Announces Retirement of Han Myint as Chief Medical Officer, Effective July 1, 2024